Edwards Lifesciences (EW) said Thursday it continues to expect 2025 adjusted earnings of $2.56 to $2.62 per share.

Analysts polled by FactSet expect $2.59.

The company also reiterated its sales growth for the year at the high end of the 9%-to-10% range.

The company said it expects 2026 adjusted EPS of between $2.80 and $2.95.

Analysts surveyed by FactSet expect $2.87.

Edwards expects sales for the year to be in a range of $6.4 billion to $6.8 billion.

Analysts polled by FactSet expect $6.64 billion.

Shares of Edwards Lifesciences were 1.2% higher in recent trading.

Price: 84.21, Change: +0.22, Percent Change: +0.26